The Electronic Prescribing of Controlled Substances (EPCS) security criteria are implemented to ensure the secure electronic transmission of prescription information and maintain processing integrity. The
The Drug Enforcement Administration (DEA) recently issued an announcement concerning the transfer of controlled substance prescriptions for initial filling. This change, effective August 28, gives
Third-Party Validation—Your Strategic Advantage Obtaining third-party validation through testing and certification offers a multitude of benefits to your organization. By partnering with a trusted authority
With the fight against prescription drug abuse remaining a priority in the United States; DEA’s Electronic Prescriptions for Controlled Substances (EPCS) regulations governing e-prescribing of
The Drug Enforcement Agency (DEA) recently proposed new rule changes for telemedicine prescribing of controlled substances. This rule is more restrictive than the current Covid-19
The U.S. Department of Health and Human Services (HHS) recently announced that they are extending the flexibilities related to Medicare telemedicine services due to the
Healthcare is a highly regulated industry, and ensuring compliance with regulations and laws is essential for any Health IT company. One of the most critical
Congress Eliminates the NADEAN Requirement With the Consolidated Appropriations Act of 2023, Congress eliminated the Drug Addiction Treatment Act (DATA) Waiver Program. This program required
Drummond experts can help you prepare The Drug Enforcement Administration (DEA) has announced the electronic prescribing of controlled substances (EPCS) Interim Final Rule will be
EPCS Clients: We’ve Got Your Back!
© 2023 Drummond Group. All rights reserved.
Please fill out the form below to download the guide.
Oops! We could not locate your form.
Please fill out the form below to download the guide.
Oops! We could not locate your form.
Please fill out the form below to download the guide.
Oops! We could not locate your form.
